v3.26.1
Borrowings - SPV V Credit Facility (Details) - USD ($)
$ in Thousands
Mar. 17, 2026
Feb. 21, 2025
Mar. 31, 2026
Dec. 31, 2025
Aug. 06, 2025
Borrowings          
Fair value     $ 5,804,557 [1],[2] $ 5,819,755 [3],[4]  
SPV V Credit Facility          
Borrowings          
Maximum borrowing capacity $ 400,000 $ 250,000      
Debt instrument, accordion feature facility   $ 350,000      
Increase in total facility amount         $ 500,000
Interest rate, basis spread 0.30% 1.85%      
Maximum percentage of advance rate on the portfolio   75.00%      
Weighted average interest rate     5.50% 5.80%  
SPV V Credit Facility | Asset pledged as collateral          
Borrowings          
Fair value     $ 385,672 $ 301,767  
SPV V Credit Facility | Minimum          
Borrowings          
Commitment fee (in percent)   0.25%      
SPV V Credit Facility | Maximum          
Borrowings          
Commitment fee (in percent)   0.75%      
[1] All of the Company’s investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended, (the “1940 Act”), unless otherwise noted. All of the Company’s investments are issued by U.S. portfolio companies unless otherwise noted.
[2] Except as otherwise noted, because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Valuation Designee (see Note 4 in the accompanying notes to the consolidated financial statements).
[3] All of the Company’s investments are issued by eligible portfolio companies, as defined in the Investment Company Act of 1940, as amended, (the “1940 Act”), unless otherwise noted. All of the Company’s investments are issued by U.S. portfolio companies unless otherwise noted.
[4] Except as otherwise noted, because there is no readily available market value for these investments, the fair value of each of these investments is determined in good faith using significant unobservable inputs by the Valuation Designee (see Note 4 in the accompanying notes to the consolidated financial statements).